Patient Guided Psychiatric Admissions
Patient Guided Psychiatric Admissions (Self-referral to Inpatient Beds)
To meet the requirement for increased patient involvement, several Community Mental Health Centres (CMHC) have initiated a service called "patient-guided admissions". The investigators will compare a group with "patient guided admission/self-referral to inpatient beds" with a group having treatment as usual.
It is expected that patients in the intervention group will experience more increased feeling of coping (patient activation) after 4 months and 12 months as a result of participating in "patient-guided admissions" than patients getting treatment as usual. In addition the total number of inpatient days either in the CMHC, psychiatric hospital or community rehabilitation centre is expected to be clearly lower in the intervention group than in the 'treatment-as-usual' group during one year after intake. Also the number of involuntary admissions either as inpatient or outpatient will be significant lower in the intervention group than the 'treatment-as-usual' group.The number of admissions in CMHC and psychiatric hospital, as well as the number of outpatient consultations in primary care, CMHC and psychiatric hospitals, will be lower in the intervention group than in the 'treatment-as-usual' group. Patients in the intervention group will experience improved mental health, increased feeling of coping (patient activation) and increased experience of recovery after 4 months and 12 months as a result of participating in "patient-guided admissions".
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Participants will be patients with psychosis or bipolar disorders. Patients in the intervention group will have a contract on "self-referral to inpatient beds" for one year. They can call the CMHC directly and ask for a bed for until 5 nights.
The patients in the 'treatment-as-usual' group will follow common procedures by either contacting their general practitioner, emergency department or duty doctor, and they will be offered a "self-referral to inpatient bed" contract after a year if they satisfy the inclusion criteria.
Regardless of the participation in the intervention group, the patients can also be ordinary admitted during the project period by a doctor via regular procedures in both hospital and CMHC if there is a need for this. All admissions will appear in the register data.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Trondheim, Norvegia, 7440
- St.Olavs hospital, Psykisk helsevern, Nidaros DPS
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- schizophrenia or bipolar disorder
- long term care
- established relationship with the ward
Exclusion Criteria:
- extensive substance use problems
- self-destructive behavior
- not able to consent
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: admissions contract
contract regarding "patient-guided admissions"
|
contract regarding "patient-guided admissions" starting immediately
|
|
Comparatore attivo: wait list control
1 year on waiting list
|
Patient-guided admissions contract regarding "patient-guided admissions" starting a year after.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Patient activation/coping
Lasso di tempo: 4 months
|
Patient Activation Measure (PAM 13)
|
4 months
|
|
Patient activation/coping
Lasso di tempo: 12 months
|
Patient Activation Measure (PAM 13)
|
12 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of admissions
Lasso di tempo: 12 months
|
Number of admissions in CMHC, psychiatric hospital of community rehabilitation centre
|
12 months
|
|
Total number of inpatient days
Lasso di tempo: 12 months
|
Total number of inpatient days in CMHC, psychiatric hospital or community rehabilitation centre
|
12 months
|
|
Number of outpatient consultations
Lasso di tempo: 12 months
|
Number of outpatient consultations in primary care, in CMHC and psychiatric hospital
|
12 months
|
|
Number of involuntary admissions
Lasso di tempo: 12 months
|
Number of involuntary admissions either as inpatient or outpatient
|
12 months
|
|
Symptoms/functioning and recovery
Lasso di tempo: 4 months
|
Behavior and symptom identification scale (BASIS 32) and Recovery Assessment Scale (RAS 24)
|
4 months
|
|
Symptoms/functioning and recovery
Lasso di tempo: 12 months
|
Behavior and symptom identification scale (BASIS 32) and Recovery Assessment Scale (RAS 24)
|
12 months
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Lasse Eriksen, PhD, St. Olavs Hospital
Pubblicazioni e link utili
Pubblicazioni generali
- Moljord IE, Helland-Hansen KA, Salvesen O, Olso TM, Gudde CB, Rise MB, Steinsbekk A, Eriksen L. Short time effect of a self-referral to inpatient treatment for patients with severe mental disorders: a randomized controlled trial. BMC Health Serv Res. 2016 Sep 22;16(1):513. doi: 10.1186/s12913-016-1712-z.
- Moljord IEO, Lara-Cabrera ML, Salvesen O, Rise MB, Bjorgen D, Antonsen DO, Olso TM, Evensen GH, Gudde CB, Linaker OM, Steinsbekk A, Eriksen L. Twelve months effect of self-referral to inpatient treatment on patient activation, recovery, symptoms and functioning: A randomized controlled study. Patient Educ Couns. 2017 Jun;100(6):1144-1152. doi: 10.1016/j.pec.2017.01.008. Epub 2017 Jan 11.
- Sigrunarson V, Moljord IE, Steinsbekk A, Eriksen L, Morken G. A randomized controlled trial comparing self-referral to inpatient treatment and treatment as usual in patients with severe mental disorders. Nord J Psychiatry. 2017 Feb;71(2):120-125. doi: 10.1080/08039488.2016.1240231. Epub 2016 Oct 14.
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 2009/1704 (Altro numero di sovvenzione/finanziamento: St Olavs Hospital)
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su admissions contract
-
Riphah International UniversityReclutamentoParalisi cerebralePakistan
-
Riphah International UniversityReclutamentoEffetti di Mulligans BLR e CR sulla flessibilità dei muscoli posteriori della coscia negli impiegatiRigidità muscolarePakistan
-
Deepak MalhotraJamia Millia IslamiaCompletatoDebolezza muscolare | Rigidità muscolareIndia
-
University of FloridaCompletatoLesioni muscolariStati Uniti